Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines ARQ Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Higher Biodesix BDSX Q1 2026 Earnings Significant EPS Beat Driven by Narrowing Losses OPTU Q1 2026 Earnings A Staggering EPS Miss Rattles Investors BK Q1 2026 Earnings EPS Beats Estimates by 13 Revenue Data Withheld Inovio Pharmaceuticals INO Holds Near Support Amid Slight Decline Cognition Therapeutics CGTX Slides 159 as Biotech Sector Headwinds Persist Nuvectis Pharma NVCT Holds Near Support After Modest Uptick Aclaris Therapeutics ACRS Edges Higher Testing Key Resistance Near 481 KD Q1 2026 Earnings EPS Miss Overshadowed by Strategic Optimism